1. Home
  2. KLXE vs VIGL Comparison

KLXE vs VIGL Comparison

Compare KLXE & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • VIGL
  • Stock Information
  • Founded
  • KLXE 2018
  • VIGL 2020
  • Country
  • KLXE United States
  • VIGL United States
  • Employees
  • KLXE N/A
  • VIGL N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • VIGL Health Care
  • Exchange
  • KLXE Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • KLXE 89.2M
  • VIGL 89.3M
  • IPO Year
  • KLXE N/A
  • VIGL 2022
  • Fundamental
  • Price
  • KLXE $4.80
  • VIGL $2.66
  • Analyst Decision
  • KLXE Hold
  • VIGL Strong Buy
  • Analyst Count
  • KLXE 1
  • VIGL 5
  • Target Price
  • KLXE $4.50
  • VIGL $21.00
  • AVG Volume (30 Days)
  • KLXE 191.8K
  • VIGL 2.6M
  • Earning Date
  • KLXE 03-05-2025
  • VIGL 03-25-2025
  • Dividend Yield
  • KLXE N/A
  • VIGL N/A
  • EPS Growth
  • KLXE N/A
  • VIGL N/A
  • EPS
  • KLXE N/A
  • VIGL N/A
  • Revenue
  • KLXE $738,000,000.00
  • VIGL N/A
  • Revenue This Year
  • KLXE N/A
  • VIGL N/A
  • Revenue Next Year
  • KLXE $4.79
  • VIGL N/A
  • P/E Ratio
  • KLXE N/A
  • VIGL N/A
  • Revenue Growth
  • KLXE N/A
  • VIGL N/A
  • 52 Week Low
  • KLXE $4.18
  • VIGL $1.49
  • 52 Week High
  • KLXE $9.80
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 36.20
  • VIGL 66.89
  • Support Level
  • KLXE $4.51
  • VIGL $2.53
  • Resistance Level
  • KLXE $6.16
  • VIGL $2.88
  • Average True Range (ATR)
  • KLXE 0.43
  • VIGL 0.30
  • MACD
  • KLXE -0.18
  • VIGL 0.06
  • Stochastic Oscillator
  • KLXE 4.75
  • VIGL 70.98

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: